Microbot Medical (MBOT) Total Current Liabilities (2010 - 2026)

Microbot Medical's Total Current Liabilities history runs 17 years deep, the most recent figure standing at $3.4 million for Q1 2026.

• Quarterly Total Current Liabilities rose 78.92% year-over-year to $3.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.4 million (up 78.92% YoY) and the FY2025 annual result came in at $3.4 million, up 39.07% from the prior year.
• Total Current Liabilities was $3.4 million for Q1 2026 at Microbot Medical, down from $3.4 million in the prior quarter.
• Across five years, Total Current Liabilities topped out at $3.4 million in Q4 2025 and bottomed at $1.2 million in Q1 2024.
• A 5-year average of $2.0 million and a median of $1.7 million in 2022 frame the typical range for Total Current Liabilities.
• Annual changes were most pronounced in 2023 — Total Current Liabilities retreated 26.39% — and 2025, when it jumped 114.0%.
• Microbot Medical's Total Current Liabilities stood at $2.1 million in 2022, then grew by 6.86% to $2.2 million in 2023, then advanced by 11.26% to $2.5 million in 2024, then soared by 39.07% to $3.4 million in 2025, then dropped by 0.99% to $3.4 million in 2026.
• Business Quant data shows MBOT's Total Current Liabilities at $3.4 million in Q1 2026, $3.4 million in Q4 2025, and $2.9 million in Q3 2025.